Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Clinical Diagnosis Track

Early GA-68-PSMA PET/MR acquisition decreases the halo-artifact around the bladder and kidneys: Lesion detectability rate and PET metrics evaluation.

Liran Domachevsky, Hanna Bernstine, Natalia Goldberg, Meital Nidam, Dorit Stern, Jacob Sosna and David Groshar
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 740;
Liran Domachevsky
3Beilinson Hospital Petah Tikva Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hanna Bernstine
6Rabin Medical Center-Beilinson Ramat Hasharon Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalia Goldberg
3Beilinson Hospital Petah Tikva Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meital Nidam
2Beilinson Petah Tikva Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorit Stern
1Assuta Hospital Tel Aviv Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Sosna
4Hadassah Hebrew University Medical Center Jerusalem Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Groshar
5Rabin Medical Center Tel-aviv Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 58 no. supplement 1 740

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2017.

Copyright & Usage 
© 2017

Author Information

  1. Liran Domachevsky3,
  2. Hanna Bernstine6,
  3. Natalia Goldberg3,
  4. Meital Nidam2,
  5. Dorit Stern1,
  6. Jacob Sosna4 and
  7. David Groshar5
  1. 1Assuta Hospital Tel Aviv Israel
  2. 2Beilinson Petah Tikva Israel
  3. 3Beilinson Hospital Petah Tikva Israel
  4. 4Hadassah Hebrew University Medical Center Jerusalem Israel
  5. 5Rabin Medical Center Tel-aviv Israel
  6. 6Rabin Medical Center-Beilinson Ramat Hasharon Israel

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2017 to April 2025

AbstractFullPdf
May 2017400
Jun 201710300
Jul 20172700
Aug 20171900
Sep 20172000
Oct 20171200
Nov 20171800
Dec 20173000
Jan 20181700
Feb 20181900
Mar 20181500
Apr 20181700
May 20181000
Jun 2018200
Jul 2018500
Aug 2018600
Sep 2018500
Oct 20181000
Nov 2018800
Dec 2018200
Jan 20191000
Feb 20191100
Mar 2019300
Apr 2019800
Jun 2019800
Jul 2019400
Aug 2019300
Sep 20191400
Oct 2019400
Nov 2019200
Dec 2019500
Jan 2020200
Feb 20201700
Mar 20201800
Apr 20201100
May 2020200
Jun 2020400
Jul 2020900
Aug 20202600
Sep 20203700
Oct 20201500
Nov 20202100
Dec 20201200
Jan 2021100
Feb 20211000
Mar 2021900
Apr 2021800
May 2021800
Jun 2021300
Jul 20211900
Aug 20214800
Sep 20211400
Oct 20211500
Nov 20219200
Dec 20215700
Jan 20229100
Feb 20222400
Mar 20221600
Apr 2022700
May 20222900
Jun 2022200
Aug 2022200
Sep 2022200
Oct 2022300
Nov 2022100
Dec 2022200
Jan 2023200
Feb 2023200
Mar 2023400
Apr 2023100
May 2023300
Jun 2023400
Jul 2023400
Aug 2023500
Sep 2023300
Oct 2023200
Nov 2023500
Dec 2023700
Jan 2024100
Feb 2024100
Mar 2024300
Apr 2024500
May 2024400
Jun 2024300
Jul 2024900
Aug 20241800
Sep 2024500
Nov 2024900
Dec 2024100
Jan 2025100
Feb 2025100
Mar 2025500
Apr 2025300
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Early GA-68-PSMA PET/MR acquisition decreases the halo-artifact around the bladder and kidneys: Lesion detectability rate and PET metrics evaluation.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Early GA-68-PSMA PET/MR acquisition decreases the halo-artifact around the bladder and kidneys: Lesion detectability rate and PET metrics evaluation.
Liran Domachevsky, Hanna Bernstine, Natalia Goldberg, Meital Nidam, Dorit Stern, Jacob Sosna, David Groshar
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 740;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Early GA-68-PSMA PET/MR acquisition decreases the halo-artifact around the bladder and kidneys: Lesion detectability rate and PET metrics evaluation.
Liran Domachevsky, Hanna Bernstine, Natalia Goldberg, Meital Nidam, Dorit Stern, Jacob Sosna, David Groshar
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 740;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Clinical Diagnosis Track

  • Immunohistochemical analysis of Gastrin-Releasing-Peptide receptor (GRPr) and Prostate-Specific- Membrane Antigen (PSMA) in primary prostate cancer: comparison with radiolabeled GRPr antagonist (68Ga-RM2) PET/CT
  • Relationship between FDG PETCT imaging and CA 125 levels in treated patients with Ovarian cancers - Can FDG PETCT define and predict the disease burden in clinically suspected recurrence ?
  • Cancer-associated fibroblasts enhance tumor 18F-FDG uptake and contribute to the intratumor heterogeneity of SUVmax
Show more Oncology, Clinical Diagnosis Track

Prostate III: PSMA Imaging

  • Influence of acquisition duration, attenuation maps and scatter correction on halo artefacts in whole-body 68Ga-PSMA PET-MRI
  • Detection of Unexpected Additional Primary Malignancies with 68Ga-PSMA PET/CT in Patients with Prostate Cancer: Frequency in 765 Patients
  • Late 68Ga-PSMA PET-scans improve lesion detectability in prostate cancer patients with biochemical relapse
Show more Prostate III: PSMA Imaging

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire